Fig. 4
From: New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors
(A) Overlay of the native co-crystallized ligand erlotinib and the docked one into the binding site of EGFR kinase (PDB ID: 4HJO). The carbon atoms of the native ligand are colored in violet, while for the docked one in orange; (B) 2D interactions of docked erlotinib with EGFR kinase.
